Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD

Abstract Inhaled bronchodilators are central for the treatment of chronic obstructive pulmonary disease (COPD), as they can provide symptom relief and reduce the frequency and severity of exacerbations while improving health status and exercise tolerance. In 2017, glycopyrrolate (GLY) delivered via...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Donald P. Tashkin, Xiaoli Niu, Sanjay Sharma, Shahin Sanjar
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Accès en ligne:https://doaj.org/article/34def7afb7e54f30b071260caa02f52c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!